| __timestamp | AbbVie Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7724000000 | 49315000 |
| Thursday, January 1, 2015 | 6387000000 | 75043000 |
| Friday, January 1, 2016 | 5855000000 | 83749000 |
| Sunday, January 1, 2017 | 6275000000 | 122682000 |
| Monday, January 1, 2018 | 7399000000 | 207761000 |
| Tuesday, January 1, 2019 | 6942000000 | 284812000 |
| Wednesday, January 1, 2020 | 11299000000 | 317875000 |
| Friday, January 1, 2021 | 12349000000 | 282660000 |
| Saturday, January 1, 2022 | 15260000000 | 451421000 |
| Sunday, January 1, 2023 | 12872000000 | 481871000 |
| Monday, January 1, 2024 | 14752000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biopharmaceuticals, effective cost management is crucial. Over the past decade, AbbVie Inc. and Sarepta Therapeutics, Inc. have demonstrated contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. AbbVie, a leader in the industry, has seen its SG&A expenses grow by approximately 66% from 2014 to 2023, peaking in 2022. This reflects its aggressive expansion and investment in marketing and administrative capabilities. In contrast, Sarepta Therapeutics, a smaller player, has increased its SG&A expenses by nearly 900% over the same period, indicating a strategic push to scale operations and enhance market presence. These trends highlight the diverse approaches companies take to balance growth and cost efficiency in a rapidly evolving market.
Breaking Down SG&A Expenses: AbbVie Inc. vs AstraZeneca PLC
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Blueprint Medicines Corporation
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: AbbVie Inc. vs Veracyte, Inc.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Madrigal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Sarepta Therapeutics, Inc. or MorphoSys AG: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Viridian Therapeutics, Inc. Trends and Insights